1446090-78-3

Basic information

• Product Name: 5-(((1S,1aR,6bS)-1-(6-(trifluoromethyl)-1H-benzo[d]imidazol-2-yl)-1a,6b-dihydro-1H-cyclopropane[b]benzofuran-5-yl)oxy)-3,4-dihydro-1,8-naphthyridin-2(1H)-one
• CAS NO: 1446090-78-3
• Molecular Weight: 478.43
• Mol File: 1446090-78-3.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: 5-(((1S,1aR,6bS)-1-(6-(trifluoromethyl)-1H-benzo[d]imidazol-2-yl)-1a,6b-dihydro-1H-cyclopropane[b]benzofuran-5-yl)oxy)-3,4-dihydro-1,8-naphthyridin-2(1H)-one(CAS DataBase Reference)
• NIST Chemistry Reference: 5-(((1S,1aR,6bS)-1-(6-(trifluoromethyl)-1H-benzo[d]imidazol-2-yl)-1a,6b-dihydro-1H-cyclopropane[b]benzofuran-5-yl)oxy)-3,4-dihydro-1,8-naphthyridin-2(1H)-one(1446090-78-3)
• EPA Substance Registry System: 5-(((1S,1aR,6bS)-1-(6-(trifluoromethyl)-1H-benzo[d]imidazol-2-yl)-1a,6b-dihydro-1H-cyclopropane[b]benzofuran-5-yl)oxy)-3,4-dihydro-1,8-naphthyridin-2(1H)-one(1446090-78-3)

Safety Data

• Hazardous Substances Data: 1446090-78-3(Hazardous Substances Data)

Upstream product

• 1446091-45-7 (1S,1aS,6bR)-5-((7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-4-yl)oxy)-1a,6b-dihydro-1H-cyclopropane[b]benzofuran-1-carboxylic acid ethyl ester 
• 1446091-43-5 (1S,1aS,6bR)-5-hydroxy-1a,6b-dihydro-1H-cyclopropane[b]benzofuran-1-carboxylic acid ethyl ester 
• 1446091-44-6 (1S,1aS,6bR)-5-((tert-butyldimethylsilyl)oxy)-1a,6b-dihydro-1H-cyclopropane[b]benzofuran-1-carboxylic acid ethyl ester 
• 1446091-46-8 (1S,1aS,6bR)-5-((7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-4-yl)oxy)-1a,6b-dihydro-1H-cyclopropane[b]benzofuran-1-carboxylic acid 
• 368-71-8 4-(trifluoromethyl)-1,2-phenylenediamine 
• 13196-10-6 benzofuran-5-ol 
• 1237535-78-2 5-fluoro-3,4-dihydro-1,8-naphthyridine-2(1H)-one 

Relevant articles and documents

FUSED TRICYCLIC COMPOUNDS AS RAF KINASE INHIBITORS

Provided are certain fused tricyclic compounds and salts thereof, compositions thereof, and methods of use therefor.

CONDENSED TRICYCLIC COMPOUNDS AS Raf KINASE INHIBITORS

PROBLEM TO BE SOLVED: To provide specific tricyclic compounds that can be useful for inhibiting Raf kinase and for treating disorders mediated by Raf kinase. SOLUTION: A compound is represented by the general formula 1 in the figure. (Q is C or N; W is C or N; X is CH2 or O; Y is NR12, O or S; Z is O, S, NR13, CO, SO, SO2 or CR13R14; R1 to R6 are each independently hydrogen, halogen, haloalkyl, alkyl or the like.) SELECTED DRAWING: None COPYRIGHT: (C)2017,JPO&INPIT

FUSED TRICYCLIC COMPOUNDS AS RAF KINASE INHIBITORS

Provided are certain fused tricyclic compounds and salts thereof, compositions thereof, and methods of use therefor.